Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute
The IMS Institute for Healthcare Informatics has looked at how the biosimilars market is evolving, finding that there will be substantial savings to payers in the 2016-2020 time frame. However, […]